NCT07605702
The Canopy Cancer Collective Clinical Registry Protocol
Not Yet Recruiting · Not specified · Canopy Cancer Collective, LLC · registry updated 2026-05-26
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The Canopy Cancer Collective Clinical Registry Protocol Non-Interventional Data and Sample Collection Registry Protocol Number of study sites 15 Study Design - Observational, registry Primary Objective To systematically collect and store comprehensive data on gastrointestinal cancer patients, encompassing both their past medical history and future clinical experiences, to address specific future research questions related to these malignancies, to establish and share best practices, and to support quality improvement initiatives focused on enhancing patient care and outcomes. Secondary Objective(s) 1. Leverage the collective to increase access to molecular profile and biomarker (ctDNA) matched clinical trials across the treatment trajectory. 2\. Use real world data and patient reported outcomes to improve patient care throughout the treatment trajectory. Research Procedure(s) Collection of clinical and outcome data and cataloging and facilitating access to physical biological specimens and their associated data for future research purposes....
Inclusion
- Retrospective Cohort:
- Must have reached the age of majority in the jurisdiction where enrolled (18 years; Alabama/Nebraska 19; Puerto Rico 21).
- Must have histologically proven GI cancer seen at the site within the 20 years preceding activation, and are:
- Deceased, or
- Lost to follow-up ( \>1 year lapse in contact since last visit).
- Prospective Cohort:
Exclusion
- Retrospective Cohort:
- \. Cases in which patient's medical chart denotes restricted use of health information.
- Prospective Cohort:
- \. Prisoners will not be approached for participation.